129 related articles for article (PubMed ID: 10049250)
1. In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems.
Weiss WJ; Petersen PJ; Jacobus NV; Lin YI; Bitha P; Testa RT
Antimicrob Agents Chemother; 1999 Mar; 43(3):454-9. PubMed ID: 10049250
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Sader HS; Jones RN
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K
Jpn J Antibiot; 2001 Sep; 54(9):473-90. PubMed ID: 11729712
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activities of carbapenems against clinical isolates].
Murase M
Jpn J Antibiot; 1999 Nov; 52(11):667-79. PubMed ID: 10659443
[TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide.
Hoban DJ; Jones RN; Yamane N; Frei R; Trilla A; Pignatari AC
Diagn Microbiol Infect Dis; 1993; 17(4):299-305. PubMed ID: 8112045
[TBL] [Abstract][Full Text] [Related]
8. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
Igari J; Watanabe N; Uehara N; Inoue M; Yoshida H; Imafuku Y; Nishino T; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Matsuoka K; Oguri T; Ohba Y; Kumasaka K; Tokuda K; Kobayashi Y; Hongo T; Okada J; Sasaki T; Matsumoto N; Hirata Y; Nakasaki N; Ono J; Takata T; Kawaguchi R; Ohtaki Y; Kajimura K; Ishigo S; Hashimoto T; Aoki N; Okamoto E; Murakami E; Saeki H
Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of meropenem against clinical isolates obtained in Canada.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
[TBL] [Abstract][Full Text] [Related]
10. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
Kitzis MD; Acar JF; Gutmann L
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
[TBL] [Abstract][Full Text] [Related]
12. The postantibiotic effect of meropenem and imipenem on selected bacteria.
Nadler HL; Pitkin DH; Sheikh W
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
[TBL] [Abstract][Full Text] [Related]
13. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
[TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial properties of meropenem towards clinical isolates, beta-lactamase producers and laboratory mutants.
Wiedemann B; Zühlsdorf M
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():197-205. PubMed ID: 2681124
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial in vitro-activity of meropenem against 200 clinical isolates in comparison to 11 selected antibiotics.
Lang C; Beuth J; Ko HL; Tunggal L; Pulverer G
Zentralbl Bakteriol; 1992 Dec; 277(4):485-92. PubMed ID: 1303691
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of biapenem, a new carbapenem antibiotic.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):377-84. PubMed ID: 8354306
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
20. THF carbapenems. Wyeth Ayerst.
Jiraskova N
Curr Opin Investig Drugs; 2001 Aug; 2(8):1035-8. PubMed ID: 11892910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
